Jin Medical International (ZJYL)

Jin Medical International stock price today, ATLAS forecast and fair value

Healthcare · Medical Instruments & Supplies · NASDAQ

$1.94▼ -5.37%

Prices as of Oct 26, 2026 · USD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

45%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Jin Medical International in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Jin Medical International

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Jin Medical International a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between $1.63 and $2.19; in 9 out of 10, between $1.26 and $2.85. Estimated annual volatility is 78%.

Price, last 12 months (weekly close)

Key numbers

P/E ratio: 123.5
52-week high: $6.04
52-week low: $1.53
Revenue (12 months): $19.7M
Revenue growth (YoY): -12.0%
Earnings growth (YoY): -50.0%
Gross margin: 29.2%
Operating margin: 2.9%
Net margin: 6.7%
Return on equity: 4.0%
Free cash flow (12 months): $-7.5M
Beta: 7.33

What this means

ATLAS does not publish a fair value for ZJYL right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks ZJYL has traded between $1.53 and $6.04. Today it is 67.9% below that high and 27% above its low.

On the business: revenue fell 12.0% year over year; net margin is 6.7%; it trades at 123.5 times earnings.

Its beta is 7.33: it tends to move more than the market, both up and down.

About the company

Jin Medical International Ltd. Class A Ordinary Shares represents equity in Jin Medical International Ltd., a healthcare equipment company focused on rehabilitation medical products and mobility support solutions.

Want to see everything about Jin Medical International?

Get started →

Plans from €3.99 a month.

Frequently asked questions

What does Jin Medical International do?

What is the chance ZJYL goes up next month?

45%: close to a coin flip. In half of the simulated outcomes, ZJYL ends the month between $1.63 and $2.19.

How big is Jin Medical International and what is its P/E ratio?

Its price-to-earnings (P/E) ratio is 123.5: you pay $123.5 for each $1 of yearly earnings.

How volatile is ZJYL?

ATLAS estimates annual volatility at 78%. In a typical month, half of the outcomes end between $1.63 and $2.19.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer